Anti-SLAMF7 antibody, elotuzumab, does not induce significant ADCC against chronic lymphocytic leukemia B-cells
BackBibliographic information
- Publication year
- 2025
- Category
- V2 — The scientific output of a publication activity as part of an edited book or collection
- CREPČ / EPCA ID
- 0047728
- Document type
- N/A
- Source
- 72nd Czech-Slovak pharmacological days abstract book
- ISBN (Source)
- 978-80-574-0420-0
- Volume
- S. 40
- Issue
- 1. vyd.
- Source publication year
- 2025
- Output type
- abstract from the event
- Language
- English
- Note
- zmena kategórie podľa OHPČ
Bibliographic record
ŠARIŠSKÝ, Marek - KĽOC, Dominik - DUBIKOVÁ, Bianca - CUPROVÁ, Michelle - TEJOVÁ, Martina - KURHAJEC, Slavomír - SÝKORA, Ján - GUMAN, Tomáš. Anti-SLAMF7 antibody, elotuzumab, does not induce significant ADCC against chronic lymphocytic leukemia B-cells. In: Czech-Slovak pharmacological days. 72nd Czech-Slovak pharmacological days abstract book : abstract book. 1. vyd. Košice : UPJŠ, 2025. ISBN 978-80-574-0420-0, s. 40.
Publication authors
| Author | Role | Share |
|---|---|---|
| Marek Šarišský | Author | 0.000 % |
| Dominik Kľoc | Author | 0.000 % |
| Bianca Dubiková | Author | 0.000 % |
| Michelle Cuprová | Author | 0.000 % |
| Martina Tejová | Author | 0.000 % |
| Slavomír Kurhajec | Author | 0.000 % |
| Ján Sýkora | Author | 0.000 % |
| Tomáš Guman | Author | 0.000 % |